e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Tuberculosis, pneumonia and vaccinations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
²Cost analysis of tuberculosis Directly Observed Treatment Strategy (DOTS) at chest dispensaries²
A. A. Eltobgy, F. H. Saleh (Cairo, Egypt; Abu Dhabi, United Arab Emirates)
Source:
Annual Congress 2005 - Tuberculosis, pneumonia and vaccinations
Session:
Tuberculosis, pneumonia and vaccinations
Session type:
Thematic Poster Session
Number:
954
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Eltobgy, F. H. Saleh (Cairo, Egypt; Abu Dhabi, United Arab Emirates). ²Cost analysis of tuberculosis Directly Observed Treatment Strategy (DOTS) at chest dispensaries². Eur Respir J 2005; 26: Suppl. 49, 954
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
E-DETECT TB Project: Outreach for Early Tuberculosis Diagnosis
Source: ERS webinars 2019 - E-DETECT TB Project: Outreach for Early Tuberculosis Diagnosis
Year: 2019
Evaluation of a tuberculosis control programme based on case-finding
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013
Monitoring of mycobacterium tuberculosis presence on the objects of TB hospital
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Latent TB infection: Patient choices and completion of treatment
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Home based tuberculosis (TB) care program
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Efficiency of MDR-TB therapy with the use of thioureidoiminomethylpyridinii perchlorate
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016
Improved treatment outcome of MDR-TB in Eastern Taiwan: Reducing default rate by DOTS Plus
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Clinical Characteristics and Treatment Outcome of Multidrug-Resistant Tuberculosis (MDR-TB) in a Tertiary Centre in Malaysia: A Two-year Experience
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Selection of patients from Pulmonary Rehabilitation (PR) to Disease Management (DM) programmes
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017
Evaluation of 123 Cases with MDR TB (Multidrug Resistant Tuberculosis) Treatment
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018
TB or not TB: update from the ERS Respiratory Infection Assembly 10
Source: Eur Respir J 2010; 36: 665-670
Year: 2010
Clinical profile of MDR-TB patients and their early response to DOTS PLUS: An Indian perspective
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Monitoring during and after tuberculosis treatment
Source: Eur Respir Monogr 2018; 82: 308-325
Year: 2018
Collapse therapy in cavitary pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Preventing MDRTB in Europe: Drug sensitivities received after the initial phase of treatment
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Steps of bedaquline implementation in Georgia
Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline
Year: 2016
Treatment of MDR-TB
Source: International Congress 2015 – CC1 Diagnosis and management of MDR-TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept